The CTSK gene gives your body instructions to make cathepsin K, a protein that helps break down old bone so new bone can be shaped normally. This gene plays an important role in bone remodeling, especially in the cells that remove worn bone during growth and repair. If the gene does not work properly, bones may become unusually dense but still break more easily, and some people may have short stature, dental changes, or differences in the shape of the skull and fingers. Pathogenic variants in the CTSK gene are linked to pycnodysostosis, a rare inherited bone condition.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or guide processes throughout the body. Some genes provide the directions for producing proteins, which are the functional parts of cells. Others are mainly involved in regulating when certain processes happen, where they take place, and how active they are. As a group, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medications. More detailed information on this topic is available in the LearnHub.
Overview
CTSKGene function
What if the gene works
The CTSK gene helps make a protein used by bone cells to break down old bone. This supports normal bone remodeling, which helps bones stay strong and keeps the skeleton healthy.
Risk
What if the gene does not work
Variants in the CTSK gene mainly cause pycnodysostosis, a condition affecting bone remodeling with short stature, dense but fragile bones, and dental or skull changes. Milder and more severe variants can influence which features appear and how marked they are.
Treatment
What does that mean for your treatment
No treatment or drug choice tailored to pathogenic variants in the CTSK gene is currently established. The CTSK gene is being studied as a drug target in bone diseases, but this has not produced a treatment approach for CTSK-related conditions.
Conditions associated with CTSK
Gene function
What if the gene works
Bone is constantly being renewed, and the CTSK gene helps with the breakdown side of that cycle. It gives bone-removing cells instructions to make a protein that cuts through old bone matrix, especially collagen. This steady cleanup supports normal bone remodeling, the everyday process of breaking down old bone so new bone can replace it.
Bone-removing cells use the CTSK protein to clear away older bone at the surface. This is a key step in normal bone remodeling, which helps your skeleton adjust to everyday wear.
One of its main jobs is cutting type I collagen, the tough protein framework that gives bone much of its structure. Breaking down this scaffold lets worn bone be removed in a controlled way.
The CTSK protein also helps break down other proteins within old bone matrix after the area is prepared for removal. That cleanup makes room for fresh bone to be laid down during normal bone renewal.
What is a variant?
A genetic variant is a small change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
CTSK gene variants can change the cathepsin K protein so it folds poorly, is cut incorrectly into its active form, or has much lower enzyme activity. In the CTSK gene, milder variants may leave some activity, while more disruptive variants can produce a shortened protein or none at all. This range of functional loss helps explain why pycnodysostosis can vary, with some people developing earlier or more marked features.
How variants are linked to conditions
Pathogenic variants in the CTSK gene cause pycnodysostosis, and the link between CTSK gene variants and pycnodysostosis is well established. This rare inherited skeletal condition is associated with short stature, very dense bones that can still break, and characteristic changes in the skull, jaw, and teeth. When testing finds disease-causing variants in both copies of the CTSK gene, it can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CTSK, risk is mainly set by genetics rather than lifestyle. A child is affected when they inherit two changed CTSK copies, one from each parent; there is not enough evidence to say that diet, exercise, or other everyday factors meaningfully change the chance of developing the condition.
Inheritance of CTSK variants
CTSK-related pycnodysostosis follows an autosomal recessive inheritance pattern. This means a person inherits two disease-causing variants in the CTSK gene, one from each parent. Parents who each carry one CTSK variant usually do not have the condition themselves, but with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. In practical terms, how CTSK gene variants are inherited usually comes down to both biological parents quietly carrying one altered copy.
What does my CTSK result mean for my family?
For CTSK, family members are mainly affected as carriers or, less often, as someone with the condition if they inherited a changed copy from both parents. Brothers and sisters may also have pycnodysostosis or may be carriers, even if they have no clear symptoms. Other relatives, such as parents and adult children, may also carry a changed CTSK copy, so the result can matter beyond just one person.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the CTSK gene, CTSK gene genetic testing uses a blood or saliva sample to read the gene's DNA code. The lab looks for changes that may help confirm or rule out an inherited bone condition and can also clarify whether a variant runs in a family.
When should I consider getting a genetic test?
Consider CTSK genetic testing if you or your child has signs of pycnodysostosis, such as short stature, unusually dense but fragile bones, repeated fractures, or a family history of this bone condition. Testing can help confirm the cause and clarify whether other relatives may also carry the gene change.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals varies with the condition and the specific type of variant. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other aspects of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can help place a person’s experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or reacts to it at its target. This is a common reason the same treatment may work well for one person, seem weaker for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences shape a person’s response to medicines. By studying links between genes and medications, it helps explain why the same treatment can affect people differently. For many drugs, genes influence both how powerfully a medicine works and how the body handles it. This information can support more personalized and informed treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the CTSK gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication choices, so general health concerns or questions about medicines are best discussed with your doctor.
History
The CTSK gene entered medical genetics in a meaningful way when researchers linked variants in it to pycnodysostosis, a rare inherited condition affecting bone strength and growth. This connection, reported in the mid 1990s, helped explain a condition that had been recognized clinically for many years. From these first observations, research expanded steadily. Scientists then identified CTSK in bone cells called osteoclasts, which gave the discovery wider importance in bone biology. Interest in the gene also grew because pycnodysostosis has sometimes been discussed in connection with the artist Henri de Toulouse-Lautrec, though that link remains unconfirmed. Over time, CTSK became part of broader efforts to understand inherited bone conditions and possible treatments targeting bone breakdown.